Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vivo distribution of catecholamine reuptake sites in human brain gives clues to the physiopathology of MPTP-induced parkinsonism.

× No keyword cloud information.

6 in total

1. Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin.

Authors: R J D'Amato; Z P Lipman; S H Snyder
Journal: Science Date: 1986-02-28 Impact factor: 47.728

2. N-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine (MPTP) causes destruction of the nigrostriatal but not the mesolimbic dopamine system in the monkey.

Authors: D M Jacobowitz; R S Burns; C C Chiueh; I J Kopin
Journal: Psychopharmacol Bull Date: 1984

3. Chronic Parkinsonism secondary to intravenous injection of meperidine analogues.

Authors: G C Davis; A C Williams; S P Markey; M H Ebert; E D Caine; C M Reichert; I J Kopin
Journal: Psychiatry Res Date: 1979-12 Impact factor: 3.222

4. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.

Authors: J W Langston; P Ballard; J W Tetrud; I Irwin
Journal: Science Date: 1983-02-25 Impact factor: 47.728

5. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.

Authors: J A Javitch; R J D'Amato; S M Strittmatter; S H Snyder
Journal: Proc Natl Acad Sci U S A Date: 1985-04 Impact factor: 11.205

6. A two-compartment description and kinetic procedure for measuring regional cerebral [11C]nomifensine uptake using positron emission tomography.

Authors: E Salmon; D J Brooks; K L Leenders; D R Turton; S P Hume; J E Cremer; T Jones; R S Frackowiak
Journal: J Cereb Blood Flow Metab Date: 1990-05 Impact factor: 6.200

6 in total